Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KEAP1 | Q14145 | 2/20 | 0.52 |
| ▸ | NFE2L2 | Q16236 | 1/20 | 0.52 |
| ▸ | DAO | P14920 | 1/20 | 0.52 |
| ▸ | DDO | Q99489 | 1/20 | 0.52 |
| ▸ | AHR | P35869 | 2/20 | 0.47 |
| ▸ | ITK | Q08881 | 2/20 | 0.45 |
| ▸ | CYP2A6 | P11509 | 2/20 | 0.44 |
| ▸ | FLT3 | P36888 | 2/20 | 0.42 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.42 |
| ▸ | AXL | P30530 | 1/20 | 0.41 |
| ▸ | KIF11 | P52732 | 1/20 | 0.39 |
| ▸ | AKR1B1 | P15121 | 1/20 | 0.39 |
| ▸ | CCNB2 | O95067 | 1/20 | 0.39 |
| ▸ | CDK1 | P06493 | 1/20 | 0.39 |
| ▸ | CCNB1 | P14635 | 1/20 | 0.39 |
| ▸ | CCNA2 | P20248 | 1/20 | 0.39 |
| ▸ | CDK2 | P24941 | 1/20 | 0.39 |
| ▸ | CCNA1 | P78396 | 1/20 | 0.39 |
| ▸ | CDK5 | Q00535 | 1/20 | 0.39 |
| ▸ | CDK5R1 | Q15078 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20615410 | 0.84 | TNKS2 (0.50) | KEAP1NFE2L2DAODDOITK | |
| SCHEMBL12433 | 0.83 | KEAP1 (0.59) | KEAP1NFE2L2DAOAHRCYP2A6 | |
| SCHEMBL4568030 | 0.78 | DAO (0.47) | KEAP1NFE2L2DAODDOAHR | |
| SCHEMBL29993172 | 0.77 | DAO (0.55) | DAODDOAHRITKCYP2A6 | |
| SCHEMBL30807019 | 0.77 | DAO (0.55) | KEAP1DAODDOITKCYP2A6 | |
| SCHEMBL890079 | 0.77 | DAO (0.55) | KEAP1DAODDOITKCYP2A6 | |
| SCHEMBL12970589 | 0.76 | DAO (0.64) | KEAP1NFE2L2DAODDOAHR | |
| SCHEMBL475358 | 0.74 | LMNA (0.52) | KEAP1AHRITKCYP2A6AXL | |
| SCHEMBL394630 | 0.74 | CYP2A6 (0.70) | KEAP1CYP2A6KDM4EAXLMEN1 | |
| SCHEMBL8529940 | 0.74 | CYP2A6 (0.44) | KEAP1DAODDOCYP2A6KDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 99 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1829872-B1 | PROCESSES FOR PRODUCTION OF INDOLE COMPOUNDS | NISSAN CHEMICAL IND LTD (JP) | 2015-07-29 | — | — | EP | claimed |
| CN-101468964-B | Processes for producing indole compound | NISSAN CHEMICAL IND LTD | 2011-05-11 | — | — | CN | claimed |
| CN-100577659-C | Processes for producing indole compound | NISSAN CHEMICAL IND LTD | 2010-01-06 | — | — | CN | claimed |
| CN-101468964-A | Processes for producing indole compound | NISSAN CHEMICAL IND LTD (JP) | 2009-07-01 | — | — | CN | claimed |
| EP-1829872-A1 | PROCESSES FOR PRODUCTION OF INDOLE COMPOUNDS | Nissan Chemical Industries, Ltd. (JP) | 2007-09-05 | — | — | EP | claimed |
| CN-1896075-A | Processes for producing indole compound | NISSAN CHEMICAL IND LTD (JP) | 2007-01-17 | — | — | CN | claimed |
| CN-1646522-A | Process for producing indole compound | NISSAN CHEMICAL IND LTD (JP) | 2005-07-27 | — | — | CN | claimed |
| US-20250263760-A1 | MODIFIED BACTERIA FOR PRODUCTION OF NITROAROMATICS | UNIVERSITY OF FLORIDA RESEARCH FOUNDATION, INCORPORATED (US) | 2025-08-21 | — | — | US | disclosed |
| US-12319946-B2 | Methods for producing modified bacteria for production of nitroaromatics | UNIVERSITY OF FLORIDA RESEARCH FOUNDATION, INCORPORATED (US) | 2025-06-03 | — | — | US | disclosed |
| US-20250092036-A1 | COMPOUNDS AND COMPOSITIONS FOR MODULATING THE ACTIVITY OF ERK | NOVARTIS INSTITUTES FOR BIOMEDICAL RESEARCH, INC. | 2025-03-20 | — | — | US | disclosed |
| WO-2025037229-A1 | COMPOUNDS AND COMPOSITIONS FOR MODULATING THE ACTIVITY OF ERK | NOVARTIS AG (CH) | 2025-02-20 | — | — | WO | disclosed |
| US-20240229090-A1 | MODIFIED BACTERIA FOR PRODUCTION OF NITROAROMATICS | UNIVERSITY OF FLORIDA RESEARCH FOUNDATION, INCORPORATED (US) | 2024-07-11 | — | — | US | disclosed |
| US-20240229090-A1 | MODIFIED BACTERIA FOR PRODUCTION OF NITROAROMATICS | UNIVERSITY OF FLORIDA RESEARCH FOUNDATION, INCORPORATED (US) | 2024-07-11 | — | — | US | disclosed |
| US-20070083053-A1 | Process for producing indole compound | NISSAN CHEMICAL INDUSTRIES, LTD. (JP) | 2007-04-12 | — | — | US | disclosed |
| CN-1896075-A | Processes for producing indole compound | NISSAN CHEMICAL IND LTD (JP) | 2007-01-17 | — | — | CN | disclosed |
| CN-1286832-C | Process for producing indole compound | NISSAN CHEMICAL IND LTD (JP) | 2006-11-29 | — | — | CN | disclosed |
| WO-2006107784-A1 | IMIDAZOPYRIDAZINE COMPOUNDS | ELI LILLY AND COMPANY (US) | 2006-10-12 | — | — | WO | disclosed |
| CN-1646522-A | Process for producing indole compound | NISSAN CHEMICAL IND LTD (JP) | 2005-07-27 | — | — | CN | disclosed |
| US-20040116399-A1 | Inhibitors of factor Xa | MILLENNIUM PHARMACEUTICALS, INC. | 2004-06-17 | — | — | US | disclosed |
| US-20040116399-A1 | Inhibitors of factor Xa | MILLENNIUM PHARMACEUTICALS, INC. | 2004-06-17 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250092036-A1 | COMPOUNDS AND COMPOSITIONS FOR MODULATING THE ACTIVITY OF ERK | MAPK1, MAP3K1, MAPK6 | KEAP1 221/4885NFE2L2 229/4885DAO 4622/4885 |
| US-20070083053-A1 | Process for producing indole compound | IDO2, IDO1, TDO2 | KEAP1 2159/4885NFE2L2 484/4885DAO 105/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.